When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
The company has seen EV deliveries increase for seven straight quarters, even though it’s still way off the ambitious goals it promoted when it went public in 2021.
The updates were part of a series of announcements geared towards wooing developers to OpenAI’s ecosystem, including the launch of an agent-building tool and the ability to build apps in ChatGPT.